-- 上游能源公司康斯托克資源公司(Comstock Resources,股票代碼:CRK)週一公佈了第一季財報,數據顯示總產量為979.19億立方英尺當量(MMcfe),低於去年同期的1150.91億立方英尺當量。 該公司第一季天然氣產量為978.55億立方英尺,低於去年同期的1150.29億立方英尺,這反映出其營運受到天氣相關因素的影響,導致產量下降。 康斯托克表示,截至3月31日的第一季石油產量為1.1萬桶,高於去年同期的1萬桶。 該公司第一季每日平均產量為10.88億立方英尺當量,低於去年同期的12.79億立方英尺當量。 康斯托克公司表示,第一季該公司已售出13口自營油井,其中包括10口位於海恩斯維爾老油田的油井,初始平均日產量為3,100萬立方英尺(MMcf/d)。 該公司也表示,已售出6口位於海恩斯維爾西部油田的油井,初始平均日產量為2,900萬立方英尺(MMcf/d)。 康斯托克公司預計,2026年剩餘時間內產量將反彈,全年目標產量為12.5億立方英尺當量/日(MMcfe/d)至14億立方英尺當量/日(MMcfe/d)。 該公司計劃於2026年在海恩斯維爾西部油田鑽探21口油井,並售出20口油井;同時,預計將在海恩斯維爾老油田鑽探50口油井,並售出48口油井。 康斯托克公司正在推進其位於德克薩斯州的發電樞紐項目,該項目將擁有高達5.2吉瓦的燃氣發電裝置容量,預計到2031年,每日天然氣供應量將接近10億立方英尺。 該公司預計,與以往相比,2026年鑽井效率的提高和完井設計的改進將提升生產率並降低成本,從而支持更高的產量和營運績效。 康斯托克資源公司計劃在2026年投入14億至15億美元的資本支出。
Related Articles
Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%
Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.